NPC Closeup 08/31/2002


Talrijik, Mind Killer of the Scars



Talrijik, Psion 2 (CR 2)

Talrijik: Male half-elf Psion 2 (Shaper); CR 2; Medium-size humanoid; HD 2d4+2; hp 7; Init +0; Spd 30 ft.; AC 14, touch 10, flat-footed 14; Atk +1 melee (1d6-1, masterwork sickle), or +1 ranged (1d8/19-20, light crossbow); SA psionic combat modes (ego whip, id insinuation, mind thrust; mental barrier, thought shield); SQ half-elf traits, psionic power points 5/day; AL NE; SV Fort +1, Ref +0, Will +5; Str 9, Dex 10, Con 12, Int 18, Wis 15, Cha 16. Height 5 ft. 6 in.

Skills and Feats: Alchemy +9, Appraise +9, Concentration +6, Craft (gemcutting) +5, Disguise +8, Gather Information +5, Knowledge (psionics) +9, Listen +3, Move Silently +2, Psicraft +9, Remote View +9, Search +5, Spot +3, Inner Strength.

Half-Elf Traits: Talrijik is immune to sleep spells and effects. He has a +2 racial bonus on saves against enchantment spells or effects, as well as low-light vision (can see twice as far as a human in low-light conditions). Talrijik also has a +1 racial bonus on Listen, Spot, and Search checks (already figured into the statistics given above).

Powers Known: (3/2; base DC = 14 + power level): 0 -- bolt, finger of fire, lesser natural armor; 1st -- astral construct I, lesser metaphysical weapon.

Possessions: Masterwork sickle, light crossbow, 20 bolts, +1 studded leather armor, potion of cure light wounds (2), potion of spider climb, potion of hiding, potion of sneaking.

Psicrystal: The psicrystal possesses the following traits and abilities: 6 Intelligence, Sneak personality (+2 to owner's Move Silently checks; already factored above), sighted, and empathic link.

Recent NPC Closeups
(MORE)
Recent Articles
(MORE)

About Us Jobs New to the Game? Inside Wizards Find a Store Press Help Sitemap

©1995- Wizards of the Coast, Inc., a subsidiary of Hasbro, Inc. All Rights Reserved.

Terms of Use-Privacy Statement

Home > Games > D&D > Articles 
You have found a Secret Door!
Printer Friendly Printer Friendly
Email A Friend Email A Friend
Discuss This Article Discuss This Article